Alembic Pharma raised $100m via QIA.

Synopsis

India investors Tata Mutual Fund, HDFC Life, Sundaram, Bajaj Life and Nippon India Mutual Fund completed a $100m investment in Alembic Pharma, an Indian multinational pharmaceutical company.

Principals

target

Alembic Pharma

bidder

Tata Mutual Fund

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

hdfc bank

financial advisors

target

Deals

£ 4.30 B

Total Value

monarch networth capital

brokers

target

Deals

£ 76 M

Total Value